This inventor holds 3 USPTO granted patents, plus 1 CIPO patent. Top assignees: Université Pierre Et Marie Curie (Paris 6), Universitéde Liége. Active years: 2015-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 158 
3 out of 86 
Years Active: 2015-2017
Title: Chahrazade Yerroum-El Amri: Innovator in Pharmaceutical Research
Introduction
Chahrazade Yerroum-El Amri, a talented inventor based in Ermont, France, has made significant contributions to the field of pharmaceuticals. With three patents to his name, he is especially noted for his research on coumarin derivatives that hold promise for treating skin diseases.
Latest Patents
Chahrazade's latest patents focus on the use of coumarin derivatives for the preparation of drugs aimed at treating skin diseases. Notably, he has developed a compound of formula (I-1) that exhibits various chemical configurations, wherein n can equal 0 or 1, Z represents O or S, and R1 includes a range of functional groups, including hydrogen and C1-C7 alkyls, that may be substituted by halogens or other functional groups. This formulation aims to target pathologies involving overactivity of the kallikrein family, presenting a significant advancement in therapeutic options.
Career Highlights
Chahrazade has worked at prestigious institutions, including Université Pierre et Marie Curie and Université de Liège. His research has helped pave the way for important innovations in drug development and the treatment of skin conditions. His focus on coumarin derivatives underpins his efforts to create effective solutions for medical challenges.
Collaborations
Throughout his career, Chahrazade has had the pleasure of collaborating with notable colleagues such as Michele Reboud-Ravaux and Xiao Tan. These partnerships have further enriched his research endeavors and contributed to the development of innovative pharmaceutical solutions.
Conclusion
Chahrazade Yerroum-El Amri exemplifies the spirit of innovation in the pharmaceutical industry. His pioneering work with coumarin derivatives not only showcases his expertise as an inventor but also provides hope for advancements in treating skin diseases. As he continues to build upon his research, the impact of his inventions is sure to be felt in the medical field for years to come.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile